Literature DB >> 1489520

Oncogenes and tumor suppressor genes: new biochemical tests.

E P Diamandis1.   

Abstract

Oncogenes and tumor suppressor genes are genes involved in cell proliferation and differentiation. They play a crucial role in the initiation and progression of cancer. Some of these genes are found to be altered in human cancers, i.e., mutated, amplified, deleted, translocated, or abnormally regulated. Recently, the protein products of the genes have been purified, and antibodies against them have been developed. Studies of oncogenes and tumor suppressor genes at the DNA, mRNA, or protein level may reveal new ways for diagnosis, monitoring, prognosis, and treatment of cancer. In this article, the area of oncogenes and tumor suppressor genes is reviewed, with emphasis on clinical applications and biochemical testing. Although most of the currently known genetic markers are not sufficiently specific or sensitive, it is anticipated that the discovery of newer markers and the application of new analytical techniques may help in devising biochemical testing suitable for screening and early diagnosis of malignant diseases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1489520     DOI: 10.3109/10408369209114603

Source DB:  PubMed          Journal:  Crit Rev Clin Lab Sci        ISSN: 1040-8363            Impact factor:   6.250


  3 in total

1.  Titration of serum p53 antibodies in patients with gastric cancer: a single-institute study of 40 patients.

Authors:  Keiji Shimizu; Yuji Ueda; Hisakazu Yamagishi
Journal:  Gastric Cancer       Date:  2005       Impact factor: 7.370

Review 2.  Molecular genetics of neurofibromatosis type 1 (NF1).

Authors:  M H Shen; P S Harper; M Upadhyaya
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

Review 3.  Role of Molecular Biology in Cancer Treatment: A Review Article.

Authors:  Aman Imran; Hafiza Yasara Qamar; Qurban Ali; Hafsa Naeem; Mariam Riaz; Saima Amin; Naila Kanwal; Fawad Ali; Muhammad Farooq Sabar; Idrees Ahmad Nasir
Journal:  Iran J Public Health       Date:  2017-11       Impact factor: 1.429

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.